Subtyping of Insomnia

Completed

Conditions: insomnia
sleeplessness
10040991

Registration Number: NL-OMON48782

Lead Sponsor: Epilepsiecentrum Kempenhaeghe

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 60

Inclusion Criteria

- Patients who are referred to Kempenhaeghe for CBT-I
- Age older than 18
- Subjective problems with falling asleep or maintaining sleep
- A duration of insomnia of more than three months
- The sleep disturbance causes clinically significant distress or impairment
Patients who live at a driving distance of less than approximately 70 km from Kempenhaeghe. This includes the regions Limburg-Noord, Brabant-Noord, Brabant-Zuidoost, Midden-Brabant and Gelderland-Zuid.

Exclusion Criteria

-Patients with conditions which will prevent taking part in neuropsychological tests, for example due to language problems
- Pregnancy
- Insomnia that occurs exclusively during the course of a mental disorder or due to medication or drug abuse
- Patients who are incompetent to provide informed consent
- Patients who are not able to adhere to the study protocol due to severe neurologic or psychiatric disorders, for example schizophrenia or alcohol abuse

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoints of the study are the different subtypes of insomnia and<br /><br>their relevant characteristics. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The fist secondary endpoint of the study is the difference of the<br /><br>characteristics of the subtypes, regarding the following parameters:<br /><br>- Demographic parameters (age, gender, educational level)<br /><br>- CBT-I treatment result<br /><br>- Results of emotional priming test<br /><br>- Results of time estimation tests<br /><br>- Results of questionnaires<br /><br>- Use of hypnotics<br /><br>- (Psychiatric) comorbidities, depression<br /><br><br /><br>The second secondary endpoint is the validity and reliability of HF measured by<br /><br>wrist-worn PPG.</p><br>